ecancer

AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells

Anthony Williams - Keck School of Medicine, University of Southern California

30 Apr 2009

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease

Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital

30 Apr 2009

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan

31 Mar 2009

Managing cardiotoxicity while treating cancer

Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan

18 Mar 2009

Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York

19 Feb 2009

How azacitidine works

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York

19 Feb 2009

Effects of Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York

19 Feb 2009

Azacitidine for Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York

19 Feb 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version

16 Feb 2009

Clinical Requirements Regarding In Silico Oncology

Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland

23 Jan 2009

Breast Cancer Cell Apoptosis

Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Dana-Farber Cancer Institute

9 Jan 2009

Haematologist, Baltimore, USA

Dr. Michael Auerbach

3 Dec 2008

More from ecancer